Does MEGLUMINE Cause Maternal exposure timing unspecified? 13 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Maternal exposure timing unspecified have been filed in association with MEGLUMINE. This represents 2.2% of all adverse event reports for MEGLUMINE.
13
Reports of Maternal exposure timing unspecified with MEGLUMINE
2.2%
of all MEGLUMINE reports
11
Deaths
12
Hospitalizations
How Dangerous Is Maternal exposure timing unspecified From MEGLUMINE?
Of the 13 reports, 11 (84.6%) resulted in death, 12 (92.3%) required hospitalization, and 13 (100.0%) were considered life-threatening.
Is Maternal exposure timing unspecified Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MEGLUMINE. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does MEGLUMINE Cause?
Off label use (389)
Maternal exposure during pregnancy (300)
Joint swelling (294)
Pemphigus (289)
Glossodynia (288)
Inflammation (285)
Pain (284)
General physical health deterioration (283)
Folliculitis (282)
Hypertension (282)
What Other Drugs Cause Maternal exposure timing unspecified?
RITUXIMAB (402)
METHOTREXATE (350)
ADALIMUMAB (343)
DICLOFENAC (331)
TOCILIZUMAB (327)
HYDROXYCHLOROQUINE (309)
FOLIC ACID (304)
INFLIXIMAB (303)
LEFLUNOMIDE (302)
SECUKINUMAB (301)
Which MEGLUMINE Alternatives Have Lower Maternal exposure timing unspecified Risk?
MEGLUMINE vs MELATONIN
MEGLUMINE vs MELOXICAM
MEGLUMINE vs MELPERONE
MEGLUMINE vs MELPHALAN
MEGLUMINE vs MEMANTINE